These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24283668)

  • 1. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
    Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
    J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of MicroRNAs in Hepatitis C Virus-Mediated Liver Disease Between African Americans and Caucasians: Implications for Racial Health Disparities.
    Devhare PB; Steele R; Di Bisceglie AM; Kaplan DE; Ray RB
    Gene Expr; 2017 Feb; 17(2):89-98. PubMed ID: 27765085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
    Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.
    Chen RX; Song HY; Dong YY; Hu C; Zheng QD; Xue TC; Liu XH; Zhang Y; Chen J; Ren ZG; Liu YK; Cui JF
    PLoS One; 2014; 9(3):e88543. PubMed ID: 24614035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Down-Regulation of Urea Cycle Generates Clinically Relevant Proteomic Signature in Hepatocellular Carcinoma Patients with Macrovascular Invasion.
    Cao Y; Ding W; Zhang J; Gao Q; Yang H; Cao W; Wang Z; Fang L; Du R
    J Proteome Res; 2019 May; 18(5):2032-2044. PubMed ID: 30901224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
    Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
    Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
    Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.
    Li N; Long Y; Fan X; Liu H; Li C; Chen L; Wang Z
    J Exp Clin Cancer Res; 2009 Aug; 28(1):122. PubMed ID: 19715608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
    Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
    Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative quantitative proteomics unveils proteostasis imbalance in human hepatocellular carcinoma developed on nonfibrotic livers.
    Negroni L; Taouji S; Arma D; Pallares-Lupon N; Leong K; Beausang LA; Latterich M; Bossé R; Balabaud C; Schmitter JM; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J; Chevet E
    Mol Cell Proteomics; 2014 Dec; 13(12):3473-83. PubMed ID: 25225353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
    Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
    Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
    De Giorgi V; Buonaguro L; Worschech A; Tornesello ML; Izzo F; Marincola FM; Wang E; Buonaguro FM
    PLoS One; 2013; 8(2):e56153. PubMed ID: 23441164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
    Gehrau RC; Archer KJ; Mas VR; Maluf DG
    PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
    Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
    Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
    Di Poto C; He S; Varghese RS; Zhao Y; Ferrarini A; Su S; Karabala A; Redi M; Mamo H; Rangnekar AS; Fishbein TM; Kroemer AH; Tadesse MG; Roy R; Sherif ZA; Kumar D; Ressom HW
    PLoS One; 2018; 13(3):e0192748. PubMed ID: 29538406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.